News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
287,754 Results
Type
Article (19639)
Company Profile (54)
Press Release (268061)
Multimedia
Podcasts (19)
Webinars (6)
Section
Business (77107)
Career Advice (731)
Deals (12696)
Drug Delivery (40)
Drug Development (43927)
Employer Resources (54)
FDA (7409)
Job Trends (6491)
News (141294)
Policy (13200)
Tag
2024 BioCapital Digital (1)
2024 BioMidwest Digital (2)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (3)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (2)
2024 Genetown Digital (3)
2024 Genetown Standard (5)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Standard (3)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
Academia (1736)
Academic (1)
Accelerated approval (1)
Adcomms (11)
Allergies (33)
Alliances (18242)
ALS (51)
Alzheimer's disease (989)
Antibody-drug conjugate (ADC) (54)
Approvals (7445)
Artificial intelligence (110)
Autoimmune disease (8)
Automation (12)
Bankruptcy (140)
Best Places to Work (5490)
BIOSECURE Act (5)
Biosimilars (20)
Biotechnology (40)
Bladder cancer (64)
Brain cancer (15)
Breast cancer (134)
Cancer (1167)
Cardiovascular disease (112)
Career advice (608)
Career pathing (14)
CAR-T (67)
Cell therapy (186)
Cervical cancer (10)
Clinical research (35565)
Collaboration (347)
Compensation (181)
Complete response letters (8)
COVID-19 (1229)
CRISPR (24)
C-suite (98)
Cystic fibrosis (60)
Data (1412)
Decentralized trials (1)
Denatured (4)
Depression (18)
Diabetes (149)
Diagnostics (2768)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (16)
Drug discovery (64)
Drug pricing (36)
Drug shortages (15)
Duchenne muscular dystrophy (55)
Earnings (31871)
Editorial (7)
Employer branding (7)
Employer resources (46)
Events (46870)
Executive appointments (318)
FDA (8080)
Featured Employer (12)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (336)
Gene editing (58)
Generative AI (9)
Gene therapy (202)
GLP-1 (389)
Government (2204)
Grass and pollen (1)
Guidances (25)
Healthcare (8975)
Huntington's disease (12)
IgA nephropathy (21)
Immunology and inflammation (44)
Indications (15)
Infectious disease (1303)
Inflammatory bowel disease (55)
Inflation Reduction Act (1)
Influenza (21)
Intellectual property (42)
Interviews (95)
IPO (6653)
IRA (13)
Job creations (1246)
Job search strategy (556)
Kidney cancer (7)
Labor market (12)
Layoffs (161)
Leadership (6)
Legal (2432)
Liver cancer (32)
Lung cancer (156)
Lymphoma (87)
Machine learning (4)
Management (15)
Manufacturing (103)
MASH (71)
Medical device (5592)
Medtech (5593)
Mergers & acquisitions (6265)
Metabolic disorders (390)
Multiple sclerosis (36)
NASH (19)
Neurodegenerative disease (47)
Neuropsychiatric disorders (11)
Neuroscience (1278)
NextGen: Class of 2025 (2660)
Non-profit (2288)
Northern California (1329)
Now hiring (32)
Obesity (187)
Opinion (72)
Ovarian cancer (38)
Pain (56)
Pancreatic cancer (35)
Parkinson's disease (77)
Partnered (8)
Patents (92)
Patient recruitment (63)
Peanut (18)
People (23417)
Pharmaceutical (14)
Pharmacy benefit managers (5)
Phase I (10598)
Phase II (15939)
Phase III (11924)
Pipeline (640)
Policy (48)
Postmarket research (1493)
Preclinical (5109)
Press Release (34)
Prostate cancer (53)
Psychedelics (10)
Radiopharmaceuticals (142)
Rare diseases (206)
Real estate (1901)
Recruiting (23)
Regulatory (9609)
Reports (12)
Research institute (1348)
Resumes & cover letters (113)
Rett syndrome (4)
RNA editing (1)
RSV (21)
Schizophrenia (41)
Series A (50)
Series B (37)
Service/supplier (3)
Sickle cell disease (25)
Southern California (1104)
Spinal muscular atrophy (77)
Sponsored (10)
Startups (1580)
Stomach cancer (4)
Supply chain (27)
Tariffs (10)
The Weekly (15)
United States (11381)
Vaccines (288)
Venture capitalists (13)
Weight loss (101)
Women's health (12)
Worklife (4)
Date
Today (145)
Last 7 days (449)
Last 30 days (1333)
Last 365 days (16331)
2025 (5073)
2024 (17373)
2023 (19715)
2022 (24196)
2021 (25580)
2020 (24255)
2019 (20622)
2018 (15713)
2017 (14358)
2016 (13676)
2015 (16567)
2014 (11625)
2013 (9167)
2012 (9771)
2011 (10017)
2010 (9023)
Location
Africa (268)
Alabama (20)
Arizona (50)
Arkansas (5)
Asia (13868)
Australia (2794)
California (2864)
Canada (903)
China (223)
Colorado (109)
Connecticut (113)
Delaware (59)
Europe (35768)
Florida (349)
Georgia (132)
Idaho (18)
Illinois (217)
India (11)
Indiana (146)
Iowa (5)
Japan (86)
Kansas (64)
Kentucky (6)
Louisiana (6)
Maine (32)
Maryland (366)
Massachusetts (2884)
Michigan (76)
Minnesota (177)
Missouri (38)
Montana (16)
Nebraska (11)
Nevada (27)
New Hampshire (30)
New Jersey (907)
New Mexico (8)
New York (900)
North Carolina (435)
North Dakota (5)
Northern California (1329)
Ohio (102)
Oklahoma (2)
Oregon (17)
Pennsylvania (623)
Puerto Rico (5)
Rhode Island (13)
South America (372)
South Carolina (10)
South Dakota (1)
Southern California (1104)
Tennessee (46)
Texas (406)
Utah (81)
Virginia (66)
Washington D.C. (19)
Washington State (298)
West Virginia (2)
Wisconsin (16)
287,754 Results for "boston biomedical associates".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Boston Scientific announces results for first quarter 2025
April 23, 2025
·
19 min read
Press Releases
Clearside Biomedical Announces Six Abstracts Accepted for Presentation at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting
March 25, 2025
·
7 min read
MASH
Boston Pharma Carves Out Monthly Treatment Niche in MASH With Strong Phase II Data
Boston Pharma’s once-monthly injection efimosfermin alfa offers a convenient dosing option for MASH patients while also achieving promising rates of fibrosis and MASH improvement, according to a Phase II readout.
November 18, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Boston Scientific announces agreement to acquire SoniVie Ltd.
March 4, 2025
·
7 min read
Press Releases
Boston Pharmaceuticals to Present the Effect of Efimosfermin Alfa on Collagen Biomarkers in Patients with F2 and F3 MASH at EASL Congress 2025
April 28, 2025
·
6 min read
Press Releases
XVIVO Presents 12-Month Follow-Up Results from European Multicenter Heart Transplantation Trial at ISHLT in Boston
April 29, 2025
·
3 min read
Press Releases
Boston Pharmaceuticals to Present State-of-the-Art Lecture and Poster for Once-monthly Efimosfermin Alfa at Digestive Disease Week® 2025
April 23, 2025
·
7 min read
Press Releases
Boston Scientific announces conference call discussing first quarter 2025 results
April 1, 2025
·
1 min read
Press Releases
BostonGene Announces Participation at the American Association for Cancer Research Annual Meeting 2025
April 21, 2025
·
4 min read
MASH
7 Late-Stage MASH Candidates That Could Reshape the Market
Akero Therapeutics, 89bio, Boston Pharmaceuticals and more are working to bring novel treatment options for metabolic dysfunction-associated steatohepatitis to a market that could reach $16 billion by 2033.
April 7, 2025
·
6 min read
·
Ben Hargreaves
1 of 28,776
Next
